Diego Villa Selected Research

Diego Villa Research Topics

Disease

19	Neoplasms (Cancer) 05/2022 - 03/2011
17	Lymphoma (Lymphomas) 12/2023 - 06/2014
10	Hodgkin Disease (Hodgkin's Disease) 11/2022 - 05/2012
9	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 05/2017
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 03/2013
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 11/2015
5	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 10/2016
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022 - 11/2014
4	Breast Neoplasms (Breast Cancer) 12/2019 - 06/2016
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 02/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2011
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2018 - 06/2013
2	Erythema elevatum diutinum 01/2018 - 01/2017
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2018 - 06/2013
2	Neutropenia 01/2018 - 02/2016
2	Disease Progression 02/2016 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 09/2012 - 06/2011
1	Triple Negative Breast Neoplasms 01/2024
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2023
1	COVID-19 12/2022
1	Plasmablastic Lymphoma 10/2022
1	Malaria 01/2021
1	Chronic Disease (Chronic Diseases) 11/2018
1	Exanthema (Rash) 01/2018
1	Leukemia 05/2017
1	Thrombocytopenia (Thrombopenia) 02/2016
1	Hepatitis C 05/2015
1	Male Breast Neoplasms (Male Breast Cancer) 02/2014
1	Human Influenza (Influenza) 07/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2013

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 12/2023 - 03/2013
7	Bendamustine Hydrochloride FDA Link 12/2023 - 02/2016
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2014
6	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 06/2014
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 06/2014
5	Prednisone (Sone)FDA LinkGeneric 12/2023 - 06/2014
5	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 06/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 06/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 05/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2012
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2017
2	ibrutinibIBA 01/2023 - 02/2016
2	Formaldehyde (Formol)FDA Link 10/2021 - 05/2017
2	Immune Checkpoint InhibitorsIBA 10/2021 - 11/2019
2	ParaffinIBA 10/2021 - 05/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 01/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2016
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 01/2016
2	Brentuximab VedotinIBA 12/2020 - 01/2018
2	AntigensIBA 07/2020 - 01/2020
2	Trastuzumab (Herceptin)FDA Link 11/2019 - 02/2014
2	Gemcitabine FDA Link 01/2019 - 05/2012
2	PlatinumIBA 12/2017 - 05/2012
2	Antiviral Agents (Antivirals)IBA 11/2016 - 05/2015
2	VaccinesIBA 07/2013 - 03/2011
2	Bevacizumab (Avastin)FDA Link 09/2012 - 06/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	CXC ChemokinesIBA 01/2022
1	InsecticidesIBA 01/2021
1	TTI-621IBA 01/2021
1	NivolumabIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 07/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Eplerenone (Inspra)FDA LinkGeneric 12/2019
1	AnthracyclinesIBA 12/2019
1	B7-H1 AntigenIBA 11/2019
1	durvalumabIBA 11/2019
1	ElementsIBA 01/2019
1	Guanosine Diphosphate (GDP)IBA 01/2019
1	Cyclin D1IBA 01/2019
1	ChromatinIBA 01/2019
1	romidepsin (FK228)FDA Link 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 10/2018
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	R-CHOP protocolIBA 10/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2016
1	Estrogen ReceptorsIBA 06/2016
1	human ERBB2 proteinIBA 06/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2016
1	Ifosfamide FDA LinkGeneric 06/2015
1	Etoposide (VP 16)FDA LinkGeneric 06/2015
1	thiamine triphosphorate (TTP)IBA 06/2014
1	Tamoxifen FDA LinkGeneric 02/2014
1	Aromatase InhibitorsIBA 02/2014

Therapy/Procedure

22	Therapeutics 12/2023 - 09/2012
20	Drug Therapy (Chemotherapy) 12/2022 - 07/2010
6	Stem Cell Transplantation 07/2020 - 03/2013
2	Transplantation 01/2023 - 06/2015
2	Radiotherapy 12/2021 - 01/2021
1	Immunotherapy 12/2022
1	Retreatment 10/2020
1	Combined Modality Therapy 10/2019
1	Precision Medicine 01/2019
1	Aftercare (After-Treatment) 05/2017
1	Autologous Transplantation 05/2016
1	Treatment Delay 01/2016
1	Hematopoietic Stem Cell Transplantation 06/2015
1	Cell Transplantation 06/2015
1	Splenectomy 05/2015